These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1940445)

  • 1. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins.
    Tanaka M; Hashimoto T; Amagai M; Shimizu N; Ikeguchi N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
    J Invest Dermatol; 1991 Oct; 97(4):725-8. PubMed ID: 1940445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
    Izumi H; Hosokawa H
    Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen.
    Korman NJ
    J Invest Dermatol; 1995 Dec; 105(6):824-30. PubMed ID: 7490478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
    Labib RS; Anhalt GJ; Patel HP; Mutasim DF; Diaz LA
    J Immunol; 1986 Feb; 136(4):1231-5. PubMed ID: 2418109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
    Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
    Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
    Murakami H; Amagai M; Higashiyama M; Hashimoto K; Chorzelski TP; Bhogal BS; Jenkins RE; Black MM; Zillikens D; Nishikawa T; Hashimoto T
    J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti-180-kD BPA antibody is an initiator.
    Kitajima Y; Hirako Y; Owaribe K; Yaoita H
    Dermatology; 1994; 189 Suppl 1():46-9. PubMed ID: 8049562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
    Zhu XJ; Niimi Y; Bystryn JC
    J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of autoantibodies against bullous pemphigoid and pemphigus antigens by an enzyme-linked immunosorbent assay using the bacterial recombinant proteins.
    Ide A; Hashimoto T; Amagai M; Tanaka M; Nishikawa T
    Exp Dermatol; 1995 Apr; 4(2):112-6. PubMed ID: 7543794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 230-kD basic protein is the major bullous pemphigoid antigen.
    Mueller S; Klaus-Kovtun V; Stanley JR
    J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
    Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
    J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.
    Rico MJ; Korman NJ; Stanley JR; Tanaka T; Hall RP
    J Immunol; 1990 Dec; 145(11):3728-33. PubMed ID: 1700993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
    Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
    Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot analysis of autoantigens in localized pemphigoid and pemphigoid nodularis.
    Kawahara Y; Matsumura K; Hashimoto T; Nishikawa T
    Acta Derm Venereol; 1997 May; 77(3):187-90. PubMed ID: 9188867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract]   [Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
    Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
    J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
    Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
    J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.